Region: Australia

Australian vaccine patent ruling shows tough new support requirements for life sciences innovators

Wyeth’s dispute with MSD underscores move towards stricter, UK-style disclosure obligations for IP rights

08 December 2020

RCEP is a leap for China but a small step for IP

World’s largest trade pact is not a show-stopper when it comes to IP, but it will bring changes to ASEAN and clouds US ability to set regional agenda

21 November 2020

Patent exhaustion finally comes to Australia

Doctrine is recognised for the first time as High Court overturns 112-year-old precedent

13 November 2020

Australian Federal Court weighs in for the first time on new claim support provision

Latest decision underscores the significance of changes to the country’s Patents Act

12 November 2020

Patents in Asia 2020: Australia

04 November 2020

The doctrine of patent exhaustion may soon be coming to Australia

High Court of Australia could overturn a 112-year-old precedent in a much-awaited ruling that will have broad commercial implications

16 September 2020

Reporting serious allegations made against the WIPO director general was not fake news, it was essential

The agency's outgoing head Francis Gurry has hit out at media coverage of complaints made against him by his deputy, but the real problem was a total lack of transparency in how the affair was handled

11 July 2020

Navigating the therapeutics market in Australia: the role of intellectual property

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2020

Australia is a sophisticated market for therapeutics and a favourable country in which to patent. Despite many changes in law and practice in recent years, patenting is relatively low in cost and quick to grant.

06 May 2020

Australia Patent Attorney Firm of the Year: FB Rice

Featured in The Global IP Awards: Key Insights from IP Leaders 2020

30 March 2020

Australian applicants plead for clarity on software patents

At IPBC Australasia in Melbourne, patent owners say more guidance from the patent office would be welcome after courts declined to clarify eligibility rules in a recent decision

21 November 2019

Get unlimited access to all IAM content